Antoine Papiernik
Director/Board Member chez SHOCKWAVE MEDICAL, INC.
Fortune : 239 664 $ au 31/03/2024
Provenance du réseau au premier degré de Antoine Papiernik
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
The Wharton School of the University of Pennsylvania
355
| College/University | Other Consumer Services | 355 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.
60
| Private Company | Investment Managers | 60 |
| Public Company | Medical Specialties | 29 | |
France Invest
 France Invest Financial ConglomeratesFinance France Invest is a French association of investors for growth that supports private equity as a lever for business creators and managers to achieve growth. The private company is based in Paris, France and was founded by Maurice Tchenio. The association is at the heart of the economy and aims to share the value created by supporting companies in their innovation and energy transition efforts.
24
| Private Company | Financial Conglomerates | 24 |
| Public Company | Pharmaceuticals: Major | 23 | |
Reflexion Medical, Inc.
 Reflexion Medical, Inc. Medical SpecialtiesHealth Technology Reflexion Medical, Inc. develops medical devices. Its products include marketwired resonate and influencers, news distribution, IR and PR hosted newsroom and media database. The company was founded by Akshay Nanduri and Samuel Mazin in 2009 and is headquartered in Hayward, CA.
19
| Holding Company | Medical Specialties | 19 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.
9
| Holding Company | Biotechnology | 9 |
| Public Company | Medical Specialties | 8 | |
Mainstay Medical Ltd.
 Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland.
8
| Subsidiary | Medical Specialties | 8 |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Fovea operates within the ophthalmic pharmaceutical market, which is expected to grow at a double-digit annual rate during the years to come. This growth is likely to be driven by new technologies and products, premium pricing facing no significant reimbursement issues, favorable trends (aging of the population, diabetes epidemiology and environmental factors) and dramatic expansion into the large and mostly untapped market for retinal degenerative diseases. With a limited number of players, the ophthalmology market has proved recently to be an early adopter of innovations, allowing new players to gain visibility very rapidly. During the last three years, Fovea has implemented this strategy, by acquiring products from large pharmaceutical or biotech companies and is actively developing them in four different indications. It has also integrated a unique drug discovery platform and has been able to identify one preclinical candidate and several interesting new targets.
7
| Extinct | Pharmaceuticals: Major | 7 |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.
7
| Holding Company | Biotechnology | 7 |
Moon Surgical SAS
 Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit.
6
| Holding Company | Medical Specialties | 6 |
Mnemo Therapeutics SAS
 Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
HighLife SAS
 HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.
5
| Holding Company | Medical Specialties | 5 |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.
5
| Extinct | Pharmaceuticals: Generic | 5 |
Pi-Cardia Ltd.
 Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.
5
| Holding Company | Medical Specialties | 5 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland.
4
| Subsidiary | Medical Specialties | 4 |
SafeHeal SAS
 SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France.
4
| Holding Company | Medical Specialties | 4 |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France.
3
| Private Company | Biotechnology | 3 |
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception.
3
| Holding Company | Biotechnology | 3 |
Gecko, Inc.
 Gecko, Inc. Financial ConglomeratesFinance Gecko, Inc. provides investment services. The CEO of the American company is Jeff Worley.
2
| Private Company | Financial Conglomerates | 2 |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy.
2
| Extinct | Pharmaceuticals: Major | 2 |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom.
2
| Extinct | Pharmaceuticals: Major | 2 |
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France.
1
| Extinct | Pharmaceuticals: Major | 1 |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA.
1
| Subsidiary | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Antoine Papiernik via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HANSEN MEDICAL, INC. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Aptus Endosystems, Inc.
 Aptus Endosystems, Inc. Medical SpecialtiesHealth Technology Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| INTERSECT ENT, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
G.I. Windows, Inc.
 G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member Chairman General Counsel Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Imperial College London | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| BIOMÉRIEUX | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Cambridge | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree | |
| University of London | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| INSEAD | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Paris Jussieu | College/University | Doctorate Degree Doctorate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
HeartWare, Inc.
 HeartWare, Inc. Medical SpecialtiesHealth Technology HeartWare, Inc. manufactures electro medical and electrotherapeutic apparatus. The company develops implantable circulatory assist devices, which are used in treating patients with congestive heart failure problems. The company was established in 2003 and is headquartered in Miramar, FL | Medical Specialties | Director/Board Member Chief Executive Officer | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | President Director of Finance/CFO | |
| EOS IMAGING | Medical Specialties | Chairman General Counsel | |
| HEARTWARE INTERNATIONAL INC | Medical Specialties | Chairman Chief Executive Officer | |
May Health SAS
 May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member President | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder Director/Board Member Director/Board Member | |
ReCor Medical, Inc.
 ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Founder | |
Sonder Capital Management LLC
 Sonder Capital Management LLC Investment ManagersFinance Sonder Capital Management LLC (Sonder Capital) is a venture capital firm founded in 2018. The firm is headquartered in Redwood City, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Founder Chief Executive Officer | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Avail Medsystems, Inc.
 Avail Medsystems, Inc. Packaged SoftwareTechnology Services Avail Medsystems, Inc. engages in medical device companies to support physicians through its nurep mobile platform. It specializes in mobile communications, customer engagement, hospital supply chain, operating room and medical devices. The company was founded by David Paul Schultz, Nick Damiano, Adam Daniel John, and Sainath Shenoy in 2012 and is headquartered in Palo Alto, CA. | Packaged Software | Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | President Founder | |
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Biotechnology | Founder Founder | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 29 |
| France | 17 |
| Royaume-Uni | 4 |
| Belgique | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Distribution Services | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 569 |
| Corporate Officer/Principal | 177 |
| Chairman | 126 |
| Independent Dir/Board Member | 116 |
| Chief Executive Officer | 100 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eli Casdin | 48 |
| Eric Rowinsky | 36 |
| Frederic Moll | 36 |
| Jay Watkins | 34 |
| Nael Jeremie Richard Kassar | 33 |
| Dieter Weinand | 32 |
| Ho Young Huh | 32 |
| Bernard Gilly | 32 |
| Nancy T. Chang | 31 |
| Catherine Moukheibir | 29 |
| Denis Lucquin | 26 |
| Nilesh Kumar | 26 |
| C. Larkin | 26 |
| Gérard Hascoët | 25 |
| Casey Tansey | 24 |
- Bourse
- Insiders
- Antoine Papiernik
- Connexions Sociétés
